STX209 (Arbaclofen) for Autism Spectrum Disorders: An 8-Week Open-Label Study.

Autor:	Erickson, Craig1, Veenstra-Vanderweele, Jeremy2, Melmed, Raun3, McCracken, James4, Ginsberg, Lawrence5, Sikich, Linmarie6, Scahill, Lawrence7, Cherubini, Maryann8, Zarevics, Peter8, Walton-Bowen, Karen8, Carpenter, Randall8, Bear, Mark9, Wang, Paul8 pwang@seasidetherapeutics.com, King, Bryan10
Zdroj:	Journal of Autism & Developmental Disorders. Apr2014, Vol. 44 Issue 4, p958-964. 7p. 3 Charts, 1 Graph.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu